Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
LB.1.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LB.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LB.1.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LB.1.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-19663.3China
LB.1.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LB.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-14553.9China
LB.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.65.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.65.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.65.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.65.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.65.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.65.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.65.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.65.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LF.1.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LF.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.1.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LF.1.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LF.1.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LF.1.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LF.1.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LF.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDVEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XDVEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDVECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XDVECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XDVEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XDVEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XDVENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDVENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KS.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KS.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KS.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KS.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KS.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KS.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KS.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KS.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
MK.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
MK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MK.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
MK.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
MK.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-20419.5China
MK.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
MK.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16984.7China
MK.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.48.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.48.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used